Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta

Molecular and Cellular Endocrinology

Volumn 392, Issue 1-2, 2014, Pages 144-151

  Burek, Malgorzata ^a   Steinberg, Katrin ^a   Förster, Carola Y ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

17beta estradiol; Blood brain barrier; Claudin 5; Estrogen receptor; Promoter; Tight junction

Indexed keywords

CLAUDIN 5; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TRANSCRIPTION FACTOR SP1; ESTRADIOL; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CLAUDIN 5 GENE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ESTROGEN RESPONSIVE ELEMENT; GENE; GENE FUNCTION; GENE IDENTIFICATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TRANSCRIPTION INITIATION; ANIMAL; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CHROMATIN IMMUNOPRECIPITATION; CLAUDIN-5; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVATION;

EID: 84901992690     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.05.003     Document Type: Article

References (48)

1. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
2. Andras I.E., Pu H., Tian J., Deli M.A., Nath A., Hennig B., Toborek M. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J. Cereb. Blood Flow Metab. 2005, 25:1159-1170.
3. Aslam M., Ahmad N., Srivastava R., Hemmer B. TNF-alpha induced NFkappaB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. Cytokine 2012, 57:269-275.
4. Bahadur U., Ganjam G.K., Vasudevan N., Kondaiah P. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor. Mol. Cell. Endocrinol. 2005, 231:1-11.
5. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
6. Boggess J.F., Zhou C., Bae-Jump V.L., Gehrig P.A., Whang Y.E. Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines. Gynecol. Oncol. 2006, 103:417-424.
7. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 2001, 103:423-428.
8. Burek M., Forster C.Y. Cloning and characterization of the murine claudin-5 promoter. Mol. Cell. Endocrinol. 2009, 298:19-24.
9. Burek M., Arias-Loza P.A., Roewer N., Forster C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 2010, 30:298-304.
10. Burek M., Salvador E., Forster C.Y. Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model. J. Vis. Exp. 2012, e4022.
11. Campbell M., Hanrahan F., Gobbo O.L., Kelly M.E., Kiang A.S., Humphries M.M., Nguyen A.T., Ozaki E., Keaney J., Blau C.W., Kerskens C.M., Cahalan S.D., Callanan J.J., Wallace E., Grant G.A., Doherty C.P., Humphries P. Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury. Nat. Commun. 2012, 3:849.
12. Darblade B., Pendaries C., Krust A., Dupont S., Fouque M.J., Rami J., Chambon P., Bayard F., Arnal J.F. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ. Res. 2002, 90:413-419.
13. Deli M.A., Abraham C.S., Kataoka Y., Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell. Mol. Neurobiol. 2005, 25:59-127.
14. Dong L., Wang W., Wang F., Stoner M., Reed J.C., Harigai M., Samudio I., Kladde M.P., Vyhlidal C., Safe S. Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J. Biol. Chem. 1999, 274:32099-32107.
15. Errede M., Girolamo F., Ferrara G., Strippoli M., Morando S., Boldrin V., Rizzi M., Uccelli A., Perris R., Bendotti C., Salmona M., Roncali L., Virgintino D. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis. J. Neuropathol. Exp. Neurol. 2012, 71:840-854.
16. Fontijn R.D., Volger O.L., Fledderus J.O., Reijerkerk A., de Vries H.E., Horrevoets A.J. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H891-H900.
17. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 2008, 130:55-70.
18. Forster C., Silwedel C., Golenhofen N., Burek M., Kietz S., Mankertz J., Drenckhahn D. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J. Physiol. 2005, 565:475-486.
19. Fujita N., Kajita M., Taysavang P., Wade P.A. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol. Endocrinol. 2004, 18:2937-2949.
20. Guido C., Panza S., Santoro M., Avena P., Panno M.L., Perrotta I., Giordano F., Casaburi I., Catalano S., De Amicis F., Sotgia F., Lisanti M.P., Ando S., Aquila S. Estrogen receptor beta (ERbeta) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 2012, 11:2911-2921.
21. Harke N., Leers J., Kietz S., Drenckhahn D., Forster C. Glucocorticoids regulate the human occludin gene through a single imperfect palindromic glucocorticoid response element. Mol. Cell. Endocrinol. 2008, 295:39-47.
22. Kleinschnitz C., Blecharz K., Kahles T., Schwarz T., Kraft P., Gobel K., Meuth S.G., Burek M., Thum T., Stoll G., Forster C. Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 2011, 42:1081-1089.
23. Krishnan V., Wang X., Safe S. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 1994, 269:15912-15917.
24. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93:5925-5930.
25. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
26. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
27. Morita K., Sasaki H., Furuse M., Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 1999, 147:185-194.
28. Nilsson S., Gustafsson J.A. Estrogen receptors: therapies targeted to receptor subtypes. Clin. Pharmacol. Ther. 2011, 89:44-55.
29. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653-660.
30. Ohtsuki S., Sato S., Yamaguchi H., Kamoi M., Asashima T., Terasaki T. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells. J. Cell. Physiol. 2007, 210:81-86.
31. Pettersson K., Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 2001, 63:165-192.
32. Porter W., Wang F., Wang W., Duan R., Safe S. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol. Endocrinol. 1996, 10:1371-1378.
33. Qin C., Singh P., Safe S. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 1999, 140:2501-2508.
34. Safe S., Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog. Nucleic Acid Res. Mol. Biol. 2004, 77:1-36.
35. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 2008, 41:263-275.
36. Samudio I., Vyhlidal C., Wang F., Stoner M., Chen I., Kladde M., Barhoumi R., Burghardt R., Safe S. Transcriptional activation of deoxyribonucleic acid polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol. Endocrinology 2001, 142:1000-1008.
37. Scholz A., Truss M., Beato M. Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium. J. Biol. Chem. 1998, 273:4360-4366.
38. Shibata H., Spencer T.E., Onate S.A., Jenster G., Tsai S.Y., Tsai M.J., O'Malley B.W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 1997, 52:141-164. discussion 164-145.
39. Stoner M., Wang F., Wormke M., Nguyen T., Samudio I., Vyhlidal C., Marme D., Finkenzeller G., Safe S. Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins. J. Biol. Chem. 2000, 275:22769-22779.
40. Sun J.M., Spencer V.A., Li L., Yu Chen H., Yu J., Davie J.R. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins. Exp. Cell Res. 2005, 302:96-107.
41. Suzuki A., Sanda N., Miyawaki Y., Fujimori Y., Yamada T., Takagi A., Murate T., Saito H., Kojima T. Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex. J. Biol. Chem. 2010, 285:13444-13453.
42. Taddei A., Giampietro C., Conti A., Orsenigo F., Breviario F., Pirazzoli V., Potente M., Daly C., Dimmeler S., Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat. Cell Biol. 2008, 10:923-934.
43. Thal S.C., Luh C., Schaible E.V., Timaru-Kast R., Hedrich J., Luhmann H.J., Engelhard K., Zehendner C.M. Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury. PLoS ONE 2012, 7:e50752.
44. Vyhlidal C., Samudio I., Kladde M.P., Safe S. Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J. Mol. Endocrinol. 2000, 24:329-338.
45. Walter P., Green S., Greene G., Krust A., Bornert J.M., Jeltsch J.M., Staub A., Jensen E., Scrace G., Waterfield M. Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci USA 1985, 82:7889-7893.
46. Xie W., Duan R., Safe S. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology 1999, 140:219-227.
47. Yuan L., Le Bras A., Sacharidou A., Itagaki K., Zhan Y., Kondo M., Carman C.V., Davis G.E., Aird W.C., Oettgen P. ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene. J. Biol. Chem. 2012, 287:6582-6591.
48. Zhao Y.L., Han W.D., Li Q., Mu Y.M., Lu X.C., Yu L., Song H.J., Li X., Lu J.M., Pan C.Y. Mechanism of transcriptional regulation of LRP16 gene expression by 17-beta estradiol in MCF-7 human breast cancer cells. J. Mol. Endocrinol. 2005, 34:77-89.